Amblyopia and Neurovascular Coupling in the Retina of Humans
Amblyopia, Regional Blood Flow
About this trial
This is an interventional diagnostic trial for Amblyopia focused on measuring Amblyopia, Retinal vessel diameters, Retinal blood flow, Flicker
Eligibility Criteria
Inclusion Criteria: Inclusion criteria for healthy subjects: Women and men, aged between 18 and 60 years Matched with regard to age, sex and smoking status Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant Normal ophthalmic findings, ametropia of less than 3.0 dpt Inclusion criteria for patients with amblyopia as a result of anisometropia or strabismus: Normal ophthalmic findings except amblyopia on one eye resulting from anisometropia or strabismus with a visual acuity between log Mar 0.3 and 0.7 (Snellen 0.2-0.5) with best correction on the amblyopic eye and 0.1 (Snellen 0.9) or better on the contralateral eye Anisometropia of more 3 dpt (patients with anisometropia) Women and men, aged between 18 and 60 years Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant Exclusion Criteria: Regular use of medication, abuse of alcoholic beverages, participation in a clinical trial in the 3 weeks preceding the study pregnancy Treatment in the previous 3 weeks with any drug Symptoms of a clinically relevant illness in the 3 weeks before the first study day Blood donation during the previous 3 weeks
Sites / Locations
- Department of Clinical Pharmacology
Arms of the Study
Arm 1
Arm 2
Other
Other
Healthy Control Subjects
Subjects with amblyopia